SK Life Science Labs
Tim Dougherty is an Associate Scientist at SK Life Science Labs, with prior experience as a Scientist at Center for Breakthrough Medicines, where the focus was on developing and qualifying analytical techniques for cell and gene therapy products. Previous roles include Research Associate at Reaction Biology Corporation, responsible for planning and executing enzymatic assays, and a Master's Student at Philadelphia College of Osteopathic Medicine, concentrating on the role of the Reelin protein in coronary vasculature formation. Tim Dougherty holds a Master of Science in Biomedical Science and a Bachelor of Arts in History from Penn State University.
This person is not in any teams
SK Life Science Labs
SK Life Science Labs, a subsidiary of SK Biopharmaceuticals, is a U.S. biotech company focused on the discovery of transformative medicines through targeted protein degradation (TPD). We discover and develop therapies through precise degradation of disease-causing proteins. Our team takes a target-centric approach through AI enabled target identification. Our core TPD platform, built upon a strong TPD knowledge base, novel E3 ligands & linkers, and machine-learning based ternary complex modeling, is further complemented by a proprietary MOPED™ molecular glue platform. SK Life Science Labs integrates innovative platforms with deep drug-hunting expertise to defeat disease and improve patients’ lives. View our community guidelines here: http://bit.ly/3REsFKU